Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Aldrich

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Breast Cancer|August 18, 2023
Monitoring of Triple Negative Breast Cancer After Neoadjuvant ChemotherapyJeffrey Aldrich, Madison Canning, Manali Bhave
Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2021
ReplySudhakar Tummala, Xerxes Pundole, Jeffrey Aldrich, et al.
Clinical Breast Cancer|November 4, 2022
Racial Disparities in Clinical Outcomes on Investigator-Initiated Breast Cancer Clinical Trials at an Urban Medical CenterJeffrey Aldrich, Princess Ekpo, Manali Rupji, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 1, 2020
Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint InhibitorsJeffrey Aldrich, Xerxes Pundole, Sudhakar Tummala, et al.
NPJ Precision Oncology|September 1, 2022
Spatially variant immune infiltration scoring in human cancer tissuesMayar Allam, Thomas Hu, Jeongjin Lee, et al.
American Journal of Hematology|February 12, 2022
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemiaJayastu Senapati, Mahran Shoukier, Guillermo Garcia-Manero, et al.
Breast Cancer Research and Treatment|February 21, 2026
Investigating initial patterns of progression on first-line treatment in patients with de novo metastatic breast cancerEmily Huber, Gaorav P Gupta, Ryan Morse, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 16, 2024
Treatment patterns and outcomes of high-grade immune checkpoint inhibitor-related pneumonitis in an oncology hospitalist serviceJoanna-Grace M Manzano, Hadeel Sahar, Jeffrey Aldrich, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Breast Cancer|August 18, 2023
Monitoring of Triple Negative Breast Cancer After Neoadjuvant ChemotherapyJeffrey Aldrich, Madison Canning, Manali Bhave
Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2021
ReplySudhakar Tummala, Xerxes Pundole, Jeffrey Aldrich, et al.
Clinical Breast Cancer|November 4, 2022
Racial Disparities in Clinical Outcomes on Investigator-Initiated Breast Cancer Clinical Trials at an Urban Medical CenterJeffrey Aldrich, Princess Ekpo, Manali Rupji, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 1, 2020
Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint InhibitorsJeffrey Aldrich, Xerxes Pundole, Sudhakar Tummala, et al.
NPJ Precision Oncology|September 1, 2022
Spatially variant immune infiltration scoring in human cancer tissuesMayar Allam, Thomas Hu, Jeongjin Lee, et al.
American Journal of Hematology|February 12, 2022
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemiaJayastu Senapati, Mahran Shoukier, Guillermo Garcia-Manero, et al.
Breast Cancer Research and Treatment|February 21, 2026
Investigating initial patterns of progression on first-line treatment in patients with de novo metastatic breast cancerEmily Huber, Gaorav P Gupta, Ryan Morse, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 16, 2024
Treatment patterns and outcomes of high-grade immune checkpoint inhibitor-related pneumonitis in an oncology hospitalist serviceJoanna-Grace M Manzano, Hadeel Sahar, Jeffrey Aldrich, et al.
Pageof 1